You may be a candidate for GLP-1 receptor agonists for BED if: You struggle with frequent binge episodes Youve tried diets and therapy with little success You have weight-related health issues like insulin resistance or prediabetes Youre looking for an evidence-based medical approach to weight loss and binge eating disorder help How to Get Started at Pure Medical Spa Chicago At Pure Medical Spa Chicago , our highly-trained staff offers medical evaluations and treatment plans focused on your unique needs
GLP-1 medications are FDA-approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27-29.9) with at least one weight-related comorbidity
Theyre naturally sweet taste provides a welcomed flavor profile that helps excite taste buds on a GLP-1 diet
Tirzepatide Research# SURPASS program (Type 2 diabetes): Five Phase 3 trials demonstrating superior HbA1c reduction compared to insulin glargine, semaglutide, and insulin degludec SURMOUNT program (Obesity): Phase 3 trials showing up to 20.9% weight loss at 72 weeks FDA approvals : Mounjaro (May 2022) for T2D
Talk with us if you have severe side effects or they dont improve
Industry analysts, including GlobalData, predict FDA approval for retatrutide in 2027, with a projected sales forecast of $15.6 billion by 2031